Biosimilars LATAM

Want to know more?

Stay tuned for event updates!



Day 1

16th February

Regulatory vision in Latin America
Anvisa - Current Brazilian regulatory scenario and the agenda
Debate: Patients association – interest in using biosimilars
Comparability in Biosimilar Development
Case study: Clinical challenges in biosimilar development
Biosimilars risk management
Case study: Challenges for biosimilar approval - The biotechnology side
The global context of Biologics, Biosimilars & Biobetters
Panel discussion: The future of biosimilars
Clinical research aspects related to the registration of a biosimilar in Brazil

Day 2

17th February

Biosimilars – market dynamics
Panel discussion with ANVISA
On-stage interview: Obstacles in the adoption of biosimilars in the healthcare system
Interchangeability – a healthcare professional perspective
The Goal Perspective of the Brazilian Health System on Biosimilars
Update on Clinical Trial Designs for Biosimilars
Biosimilars in Argentina. An experience in Latam